Mark Jacobson

Insider Reports History

Location: 200 Broadway, 3 Rd Floor, New York, NY
Signature: /s/ Mark Jacobson
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Jacobson:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Axsome Therapeutics, Inc.	Chief Operating Officer	Performance Stock Units	10.8K	$1.41M	$131.07	Feb 24, 2025	Direct
Axsome Therapeutics, Inc.	Chief Operating Officer	Restricted Stock Units	10.8K	$1.41M	$131.07	Feb 21, 2025	Direct
Axsome Therapeutics, Inc.	Chief Operating Officer	Common Stock	5.78K	$639K	$110.44	Jun 9, 2025	Direct
Axsome Therapeutics, Inc.	Chief Operating Officer	Employee Stock Option (Right to Buy)	10.9K			Feb 21, 2025	Direct
Axsome Therapeutics, Inc.	Chief Operating Officer	Stock Option (Right to Buy)	0			Jun 9, 2025	Direct

Showing 1 to 5 of 5 entries

Insider Reports Filed by Mark Jacobson

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
AXSM	Axsome Therapeutics, Inc.	Jun 9, 2025	3	-$2.56M	4	Jun 10, 2025	Chief Operating Officer
AXSM	Axsome Therapeutics, Inc.	May 27, 2025	6	-$3.97M	4	May 28, 2025	Chief Operating Officer
AXSM	Axsome Therapeutics, Inc.	Feb 21, 2025	3	$0	4	Feb 25, 2025	Chief Operating Officer
AXSM	Axsome Therapeutics, Inc.	Aug 9, 2024	3	-$3.83M	4	Aug 9, 2024	Chief Operating Officer
AXSM	Axsome Therapeutics, Inc.	May 29, 2024	3	-$570K	4	May 29, 2024	Chief Operating Officer
AXSM	Axsome Therapeutics, Inc.	Apr 1, 2024	3	-$1.87M	4	Apr 1, 2024	Chief Operating Officer
AXSM	Axsome Therapeutics, Inc.	Feb 27, 2024	2	$0	4	Feb 29, 2024	CHIEF OPERATING OFFICER
AXSM	Axsome Therapeutics, Inc.	Mar 2, 2023	2	$0	4	Mar 6, 2023	CHIEF OPERATING OFFICER
AXSM	Axsome Therapeutics, Inc.	Mar 4, 2022	2	$0	4	Mar 8, 2022	CHIEF OPERATING OFFICER
AXSM	Axsome Therapeutics, Inc.	Nov 12, 2021	1	$0	4	Nov 15, 2021	CHIEF OPERATING OFFICER